NeuroKaire
PrivateLast Round
VC Round
Dec 17, 2024
Total Funding Raised
$29.89M
Company Overview
NeuroKaire is a biotechnology company that provides a personalized medical testing tool to help physicians find the best drug therapy for patients with psychiatric and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Mental Health
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroKaire Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NeuroKaire Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 17, 2024 | ||||
| Grant | Jul 26, 2022 | ||||
| Series A | Sep 30, 2021 | ||||
| Seed | May 1, 2019 | ||||
| Accelerator | Nov 1, 2018 |
Key People
Founding team and executive leadership
NeuroKaire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Israel Innovation Authority | Seed |
| MassChallenge | Accelerator |
| Meron Capital | Series A, Seed, VC Round |
| Jumpspeed Ventures | Series A, Seed, VC Round |
| Sapir Venture Partners | Series A, Seed, Accelerator |
| GreyBird Ventures | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors grew 77% MoM, reaching 2.5K.
- Oct 30, 2025
Partnered with Compass Pathways for precision psychiatry and neurology research.
NeuroKaire Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroKaire's valuation, stock price, and market status.